NCT00361231 Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer Status COMPLETED Phase PHASE2
NCT00360360 Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site Status COMPLETED Phase PHASE2
NCT00357318 Bevacizumab and Sunitinib in Treating Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT00356889 Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors Status COMPLETED Phase PHASE2
NCT00356681 A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer Status TERMINATED Phase PHASE2
NCT00356122 Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT00354978 Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients Status COMPLETED Phase PHASE2
NCT00354679 Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer Status COMPLETED Phase PHASE2
NCT00352521 Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma Status COMPLETED Phase PHASE2
NCT00351039 Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00348998 Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer Status UNKNOWN Phase PHASE2
NCT00345761 Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00345696 1stline Study Capecitabine Administered on Continuous Way Plus Oxaliplatin&Bevacizumab Every 2weeks in Metastatic CCR. Status COMPLETED Phase PHASE2
NCT00345163 A Study to Evaluate Bevacizumab Alone or in Combination With Irinotecan for Treatment of Glioblastoma Multiforme (BRAIN) Status COMPLETED Phase PHASE2
NCT00343291 A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC Status COMPLETED Phase PHASE2
NCT00343044 Ph II Study of Wkly Topotecan + Bevacizumab in Plat. Resistant/Recurrent Gyn Cancers Status COMPLETED Phase PHASE2
NCT00337207 Bevacizumab in Treating Patients With Recurrent or Progressive Glioma Status COMPLETED Phase PHASE2
NCT00336323 A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin) Status COMPLETED Phase PHASE2
NCT00335829 Bevacizumab and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery Status COMPLETED Phase PHASE2